Hitoshi Matsuda
Fortuna: 67 472 $ al 31/07/2026
Fortuna: 67 472 $ al 31/07/2026
Hitoshi Matsuda is currently Director at GNI-EPS Pharmaceuticals, inc.
since 2013, Director at GNI Hong Kong Ltd. since 2013, and Auditor at Shanghai Genomics, Inc. since 2013.
Former positions include Chief Operating Officer & Director at GNI Group Ltd. and Director at Continent Pharmaceutical, Inc. Education includes graduate studies at Keio University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VALUENEX Japan Inc.
VALUENEX Japan Inc. Packaged SoftwareTechnology Services Develops data analytics tool 0,24 % | 31/07/2025 | 20.700 ( 0,24 % ) | 67 472 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Engages in therapeutic pharmaceutical products development and production | Comptroller/Controller/Auditor | 01/07/2013 |
GNI-EPS Pharmaceuticals, inc. | Director/Miembro de la Junta | 01/07/2013 |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holdings company with interests in clinical trial research | Director/Miembro de la Junta | 01/07/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Director/Miembro de la Junta | - |
| GNI GROUP LTD. | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Keio University
Keio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Engages in therapeutic pharmaceutical products development and production | Health Technology |
GNI Group Ltd.
GNI Group Ltd. BiotechnologyHealth Technology Engages in research and development, manufacture and sale of pharmaceutical products | Health Technology |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Health Technology |
GNI-EPS Pharmaceuticals, inc. | |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holdings company with interests in clinical trial research | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.